Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Best Pharma Strategies from the Experts

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.   At one point in his career, I Don’t Care Host Kevin Stevenson spent some…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

At one point in his career, I Don’t Care Host Kevin Stevenson spent some time on the pharma side of things, in between working at hospitals.

Today he dives back into that world with Donovan Quill, President, and CEO at Optime Care, a nationally recognized pharmacy, distribution, and patient management organization that creates the trusted path to a fulfilled life for patients with rare and orphan disorders.

“What we try to do is create a holistic program for those patients where we combine all the services you would see in a pharmacy in a patient care model,” Quill said. “We try to create a one-stop-shop for patients to really get the care they need from a support standpoint, from affordability, and also to distribute their products to them in their home or site of care.”

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand.” – Donovan Quill

Orphan disorders and drugs are a bit different from regular pharmaceuticals. Typically, an orphan drug is a treatment for a condition with less than 200,000 patients in the U.S., according to the FDA definition. But, what they do at Optime Care is treat disorders that are even more rare, or “Ultra orphan,” according to Quill.

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand,” Quill said. “We really try to focus on the patients who need a little extra care.”

Most of the time, the patients they treat have a disorder they’ve never heard of and are treated with a product they can’t pronounce, Quill said jokingly.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Healthcare AI deployments stall on data quality, not model performance

Healthcare AI deployments stall on data quality, not model performance

Healthcare AI deployments are facing challenges not with the AI models themselves, but with the data quality. Hospital CIOs report difficulties in scaling AI due to fragmented and poorly governed data. This highlights the need for better data management and governance in healthcare AI initiatives.

  • 01Data quality is a major obstacle in scaling healthcare AI deployments.
  • 02Hospital CIOs are encountering issues with fragmented data governance.
  • 03AI model performance is not the primary challenge in these initiatives.

Jul 11, 2026

NHS commits £10bn to health tech, with ambient voice and pathology digitization at the center

NHS commits £10bn to health tech, with ambient voice and pathology digitization at the center

NHS England is investing £10bn in health technology, focusing on ambient voice technology and pathology digitization. This initiative aims to improve healthcare efficiency and patient outcomes. The commitment includes integrating advanced technologies into existing healthcare systems.

  • 01NHS England commits £10bn to health tech.
  • 02Focus areas include ambient voice technology and pathology digitization.
  • 03The initiative aims to enhance healthcare efficiency and patient care.

Jul 9, 2026

Canada launches Vital, a national hospital data platform backed by $210 million, starting with 160 hospitals

Canada launches Vital, a national hospital data platform backed by $210 million, starting with 160 hospitals

Canada has introduced a national hospital data platform named Vital, which will initially connect real-time data from 160 hospitals across three provinces. The initiative is supported by $210 million in funding, with coordination provided by Unity Health Toronto. This platform aims to enhance healthcare data integration and accessibility across the country.

  • 01Vital platform will connect 160 hospitals across three Canadian provinces.
  • 02The initiative is supported by $210 million in funding.
  • 03Unity Health Toronto is coordinating the implementation of this platform.

Jul 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub